In a single-blind trial, 12-month exenatide treatment improved motor and cognitive scores compared to controls (MDS-UPDRS difference: +4.9 points
Thorpe K, Toles A, Shah B, Schneider J, Bravata DM
The medication reduces energy expenditure slightly, and when withdrawn, your body may not immediately return to pre-treatment calorie burn
Regulatory actions and ongoing monitoring To protect the drug supply chain, the FDA has implemented import controls targeting certain high-risk active pharmaceutical ingredients used in GLP-1 medications
Clarity in dosage and its conversion empowers individuals on their health journeys, ensuring they receive the benefits of this treatment safely
While DTC models may improve access and shift employer prescription costs, theres no evidence that they will solve the obesity burden or reduce total healthcare costs long-term